
A retrospective study finds that direct selective laser trabeculoplasty significantly lowers intraocular pressure, with the greatest benefit seen in treatment-naive eyes.
Dallas-Refocus Group Inc. has received approval to market its PresVIEW scleral incision system in the European Union.




